Stem Cell Based Therapy Option in COVID-19: Is It Really Promising?
Irmak Duygu Koyuncu, Darıcı Hakan, Karaöz Erdal
Table 2 Selected trials in ICTP of WHO.
Trial IDPublic titleRecruitment StatusInclusion age
minmax
ChiCTR2000029569Safety and efficacy of umbilical cord blood mononuclear cells conditioned medium in the treatment of severe and critically novel coronavirus pneumonia (COVID-19): a randomized controlled trialNot Recruiting18-
ChiCTR2000030138Clinical Trial for Human Mesenchymal Stem Cells in the Treatment of Severe Novel Coronavirus Pneumonia (COVID-19)Not Recruiting1675
ChiCTR2000029990Clinical trials of mesenchymal stem cells for the treatment of pneumonitis caused by novel coronavirus pneumonia (COVID-19)Recruiting1895
ChiCTR2000030300Umbilical cord mesenchymal stem cells (hucMSCs) in the treatment of high-risk novel coronavirus pneumonia (COVID-19) patientsRecruiting1875
ChiCTR2000031494Clinical study for stem cells in the treatment of severe novel coronavirus pneumonia (COVID-19)Recruiting1890
ChiCTR2000031430Clinical study of human umbilical cord mesenchymal stem cells in the treatment of novel coronavirus pneumonia (COVID-19) induced pulmonary fibrosisRecruiting1880
NCT04252118Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With COVID-19Recruiting1870
NCT04276987A Pilot Clinical Study on Inhalation of Mesenchymal Stem Cells Exosomes Treating Severe Novel Coronavirus PneumoniaNot yet Recruiting1875
NCT04313322Treatment of COVID-19 Patients Using Wharton’s Jelly-Mesenchymal Stem CellsRecruiting18-
NCT04315987NestCell® Mesenchymal Stem Cell to Treat Patients With Severe COVID-19 Pneumonia (HOPE)Not yet Recruiting18-
NCT04331613Safety and Efficacy of CAStem for Severe COVID-19 Associated With/Without ARDSRecruiting1870
NCT04339660Clinical Research of Human Mesenchymal Stem Cells in the Treatment of COVID-19 PneumoniaRecruiting1875
NCT04336254Safety and Efficacy Study of Allogeneic Human Dental Pulp Mesenchymal Stem Cells to Treat Severe COVID-19 PatientsRecruiting1865
NCT04288102Treatment With Mesenchymal Stem Cells for Severe Corona Virus Disease 2019 (COVID-19)Recruiting1875
NCT04302519Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp Mesenchymal Stem CellsNot yet Recruiting1875
NCT04269525Umbilical Cord (UC)-Derived Mesenchymal Stem Cells (MSCs) Treatment for the 2019-novel Coronavirus (nCOV) PneumoniaRecruiting1875